Luo et al. found that IL-37b is able bind to SMAD3 and inhibit the SMAD pathway by interfering with the formation of the SMAD2/3/4 complex and nuclear translocation in tumor cells [31]. This evidence concerns the gene SMAD2 and neoplasm.